Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1993
11/11/1993WO1993022335A1 Stable polypeptide composition
11/11/1993WO1993022331A1 Human crabp-i and crabp-ii
11/11/1993WO1993022330A1 NUCLEIC ACID PROCESS PROBES TO $i(MYCOBACTERIUM TUBERCULOSIS)
11/11/1993WO1993022267A1 Novel retinol derivatives and uses thereof
11/11/1993WO1993022058A1 Polynucleotide amplification analysis using a microfabricated device
11/11/1993WO1993022055A2 Fluid handling in microfabricated analytical devices
11/11/1993WO1993022054A1 Analysis based on flow restriction
11/11/1993WO1993022053A1 Microfabricated detection structures
11/11/1993WO1993021959A1 Bystander effect tumoricidal therapy
11/11/1993WO1993021956A1 Antibodies to p-selectin and their uses
11/11/1993WO1993021947A1 Improved production of reproductive hormones
11/11/1993WO1993021769A1 Diphtheria toxin receptor-binding region
11/11/1993WO1993020238A3 Amplification of human mdm2 gene in human tumors
11/11/1993WO1993019202A3 Exchangeable template reaction
11/11/1993WO1993018163A3 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
11/11/1993WO1993018159A3 Compositions and methods for pace 4 and 4.1 gene and polypeptides in cells
11/11/1993WO1993018146A3 Proteins forming complexes with chaperones and ligands thereof, fragments thereof, preparation thereof and biological uses thereof
11/11/1993WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides
11/11/1993CA2135298A1 Novel retinol derivatives and uses thereof
11/11/1993CA2135207A1 Protein l and process for its preparation by recombinant dna technology
11/11/1993CA2135074A1 Nucleic acid amplification oligonucleotides and probes to human hepatitis b virus
11/11/1993CA2135072A1 Methods for high resolution gene mapping
11/11/1993CA2135052A1 Diphtheria toxin receptor-binding region
11/11/1993CA2134784A1 Novel plant virus sequences
11/11/1993CA2134763A1 Bystander effect tumoricidal therapy
11/11/1993CA2134678A1 Fanconi anemia gene for complementation group c
11/11/1993CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals
11/11/1993CA2134670A1 Constitutive and inducible epidermal vector systems
11/11/1993CA2134666A1 Cdna sequence of dengue virus serotype 1 (singapore strain)
11/11/1993CA2134655A1 Modulation of thrombospondin-cd36 interactions
11/11/1993CA2134564A1 Recombinant stimulating factor of the neu receptor
11/11/1993CA2134552A1 Detection of gene sequences in biological fluids
11/11/1993CA2134550A1 Human crabp-i and crabp-ii
11/11/1993CA2134446A1 Methods for treating cotton-containing fabrics with cbh i enriched cellulase
11/11/1993CA2134443A1 Inhibitory factor
11/11/1993CA2134337A1 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum
11/11/1993CA2134198A1 Improved recombinant protein production
11/11/1993CA2133581A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin
11/11/1993CA2132968A1 Genomic mismatch scanning
11/11/1993CA2130904A1 A predictive assay for suicidal behavior
11/11/1993CA2118513A1 In vivo homologous sequence targeting in eukaryotic cells
11/11/1993CA2118320A1 Production of reproductive hormones
11/11/1993CA2111561A1 Fed batch culture method for protein secreting cells
11/10/1993EP0569240A1 Human metabotropic glutamate receptor and related DNA compounds
11/10/1993EP0569237A2 Nucleic acid amplification oligonucletodies and probes to human hepatitis B virus
11/10/1993EP0569115A2 High throughput DNA preparation system
11/10/1993EP0569042A1 Medical uses of IL-1 beta
11/10/1993EP0568925A2 TNF receptor action modulation
11/10/1993EP0568833A1 Human antithrombin III mutants
11/10/1993EP0568645A1 Mixed specificity fusion proteins
11/10/1993EP0568641A1 Regulation of nucleic acid translation
11/10/1993EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
11/10/1993EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)
11/10/1993EP0568575A1 Test and model for alzheimer's disease
11/10/1993EP0568539A1 Soluble mannose receptor peptides
11/10/1993EP0568537A1 Genetic modification of endothelial cells
11/10/1993EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors
11/10/1993EP0407411B1 ACTIVITION OF NF-kB PRECURSOR
11/10/1993CN1078262A Transgene mammal cell system representing protein in surface antigen of hepatitis B virus
11/10/1993CN1078261A Method for introducing large amount of exogenous material into living cells
11/10/1993CN1078260A Exogenous genes products made from tussah chrysalis
11/09/1993US5260432 Genetic engineering
11/09/1993US5260421 Site-directed mutagenesis modified glycoprotein hormones
11/09/1993US5260419 Cation exchange resin
11/09/1993US5260274 Factor VIII binding domain of von Willebrand Factor
11/09/1993US5260223 Methods for detection of human gamma, γ T cell receptor
11/09/1993US5260213 Fused biocontrol agents
11/09/1993US5260212 Cloned gene encoding for bacteriocin from Pediococcus acidilactici
11/09/1993US5260209 Useful for immunization to produce antibodies; diagnosis of genetic defect which causes muscular dystrophy
11/09/1993US5260208 Enantioselective amidases, DNA sequences encoding them, method of preparation and utilization
11/09/1993US5260207 Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins
11/09/1993US5260205 Anion exchange medium, elution
11/09/1993US5260204 Human manganese superoxide dismutase (hMn-SOD)
11/09/1993US5260202 Fermentation method
11/09/1993US5260201 Methods and products for facile microbial expression of DNA sequences
11/09/1993US5260200 Isolated DNA encoding an insulin receptor substrate
11/09/1993US5260199 Gene expression
11/09/1993US5260198 Without using an induction substance such as tysrosine or isopropyl thiogalactoside
11/09/1993US5260058 Bacillus thuringiensis isolates active against hymenopteran pests
11/09/1993US5260057 Method and product for the treatment of gastric disease
11/09/1993CA2095712A1 Development of a mechanism-based screen to identify androgen receptor agonists and antagonists
11/09/1993CA2095490A1 Human metabotropic glutamate receptor and related dna compounds
11/09/1993CA1324097C Inducible heat shock and amplification system
11/09/1993CA1324096C Gentamicin marker genes for plant transformation
11/09/1993CA1324095C Recombinant ricin toxin
11/09/1993CA1324094C Hepatitis a virus vaccines
11/09/1993CA1324093C Recombinant ricin a fragment and ricin toxin
11/06/1993CA2067991A1 A thermostable ligase mediated dna amplification system for the detection of genetic diseases
11/04/1993DE4225094A1 Compsn. for gene therapy, esp. of viral infections and tumours - comprises anti-sense DNA or RNA inserted into long terminal repeat or transposable element and e.g. virus envelope as carrier
11/03/1993EP0568384A1 Human glutamate receptor proteins and associated DNA compounds
11/03/1993EP0568178A1 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use
11/03/1993EP0567785A2 Protein having alpha-glucosidase activity, DNA having genetic information thereof, and production of alpha-glucosidase
11/03/1993EP0567645A1 Dna which codes for neurotrophic activity inhibitor and use thereof
11/03/1993EP0567635A1 Rapid assays for amplification products
11/03/1993EP0567630A1 Dna-sequence coding for carminomycin 4-o-methyltransferase
11/03/1993EP0567599A1 Megakaryocyte stimulating factors
11/03/1993EP0567587A1 Synthesis of full-length, double-stranded dna from a single-stranded linear dna template
11/03/1993EP0567585A1 HEPATIC GROWTH FACTOR RECEPTOR IS THE $i(MET) PROTO-ONCOGENE
11/03/1993EP0567581A1 Cell ablation using trans-splicing ribozymes
11/03/1993EP0567577A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof